Lifebit REAL uniquely combines machine learning, artificial intelligence and real world evidence, to accelerate three key areas:

Disease
Surveillance

Drug
Identification

Target
Discovery

DRUG IDENTIFICATION

Find the most promising pharmaceutical assets earlier, to strengthen your R&D portfolio.

DRUG PIPELINE ACCELERATION

Monitor the disease landscape and quantify disease occurrence, so you can prioritise your R&D pipeline accordingly.

Meet the Therapeutic Leaders

that use Lifebit REAL

Meet the Therapeutic Leaders
that use Lifebit REAL

“ We are strategically partnering with Lifebit to leverage AI to monitor and interpret scientific and other sources in real-time.

“This will accelerate the infectious diseases detection process, as the vast amounts of scientific relevant information being produced at many levels cannot be feasibly collected and analysed manually.”

Prof. Dr. Eric Haaksma,

Prof. Dr. Eric Haaksma,

Head of Animal Health Global Innovation Boehringer Ingelheim

REAL enables every scientific and commercial decision to be informed by real world data and evidence.

Dr. Ilona Carneiro, Senior Epidemiologist at Lifebit
Get started

1

Book a consultation with our experts

2

Create your blueprint for your therapeutic area

3

Get ahead of the competition and the forefront of innovation

Here to help_Ilona

 

Stay ahead of the curve with disease surveillance by Lifebit REAL


Our experts are ready to help

Resources

Boehringer-Ingelheim-lifebit-AI

Boehringer Ingelheim Partners With Lifebit to Detect Disease Outbreaks

9th Jun 2022

Lifebit & Boehringer Ingelheim partner to use AI to detect disease outbreaks globally. Utilize NLP, AI, & real-world data for fast & accurate reports.


Read more
lifebit_boehringeringelheim-1-768x384

Lifebit & Boehringer Ingelheim Join Forces to Unlock Health Data

1st Mar 2022

Boehringer Ingelheim and Lifebit Biotech partner to build data platform for drug discovery and precision medicine.


Read more